<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04990804</url>
  </required_header>
  <id_info>
    <org_study_id>210432</org_study_id>
    <nct_id>NCT04990804</nct_id>
  </id_info>
  <brief_title>Opioid Free vs. Standard Perioperative Pain Regimen for Anterior Cervical Discectomy and Fusion (ACDF) Surgery</brief_title>
  <official_title>Opioid Free vs. Standard Perioperative Pain Regimen for Anterior Cervical Discectomy and Fusion (ACDF) Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cervical Spine Research Society</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients undergoing 1-3 level Anterior Cervical Discectomy and Fusion (ACDF) at the levels&#xD;
      between C2 and T1 will be enrolled into this randomized prospective study. All patients&#xD;
      enrolled in this study will undergo a trial of non-surgical treatment prior to the&#xD;
      recommendation for surgery. After enrollment, patients will be randomized utilizing a block&#xD;
      randomization strategy to one of two treatment groups - a standard opioid-containing&#xD;
      postoperative pain regimen versus a non-opioid postoperative pain regimen. Postoperative&#xD;
      outcomes will be assessed.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be followed for 12 months and the following Specific Aims will be assessed:&#xD;
&#xD;
      Aim 1: Evaluate whether utilization of a non-opioid postoperative pain regimen after ACDF&#xD;
      leads to lower rates of new chronic opioid use when compared with postoperative pain regimens&#xD;
      utilizing opioids.&#xD;
&#xD;
      Aim 2: Evaluate whether utilization of a non-opioid postoperative pain regimen after ACDF&#xD;
      results in equivalent postoperative pain scores in the early postoperative period.&#xD;
&#xD;
      Aim 3: Evaluate whether utilization of a non-opioid postoperative pain regimen after ACDF&#xD;
      leads to equivalent clinical outcomes when compared with postoperative pain regimens&#xD;
      utilizing opioids at 3 months and 12 months.&#xD;
&#xD;
      Aim 4: Evaluate whether utilization of a non-opioid postoperative pain regimen after ACDF&#xD;
      leads to fewer postoperative complications when compared with postoperative pain regimens&#xD;
      utilizing opioids.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 2021</start_date>
  <completion_date type="Anticipated">August 2023</completion_date>
  <primary_completion_date type="Anticipated">August 2023</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized, Non-Blinded</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>New Chronic Opioid Use</measure>
    <time_frame>9-12 months</time_frame>
    <description>Opioid prescription for &gt; or = 45 days in 90 day window (9-12 months postoperatively)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative Pain</measure>
    <time_frame>Postoperative day 1, 7, 14</time_frame>
    <description>Numeric Rating Scale (NRS) arm pain and neck pain scores</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PROMIS-29</measure>
    <time_frame>3 and 12 months postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neck Disability Index (NDI)</measure>
    <time_frame>3 and 12 months postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Return to work status</measure>
    <time_frame>3 and 12 months postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction with the surgical outcome</measure>
    <time_frame>3 and 12 months postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative adverse events</measure>
    <time_frame>3 months postoperatively</time_frame>
    <description>Readmissions, adverse events, serious adverse events</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Opioid Use</condition>
  <condition>Spinal Diseases</condition>
  <condition>Surgery--Complications</condition>
  <condition>Surgery</condition>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Standard Perioperative Pain Regimen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will be provided a prescription for low dose opioids for 5 days postoperatively (Hydrocodone/Acetaminophen 5/325mg or Oxycodone/Acetaminophen 5/325mg) to be taken every 6 hours as needed for pain. Refills may be provided (Hydrocodone/Acetaminophen 5/325mg or Oxycodone/Acetaminophen 5/325mg) if requested by the patient at the providers discretion. In addition, patients will also be prescribed Gabapentin 300mg q8 hours or Pregabalin 75mg twice daily and a muscle relaxer (Methocarbamol 750mg BID or Flexeril 5-10 mg TID) as needed for spasms. Alternative muscle relaxers (Metaxalone 800 mg TID or Tizanidine 2-6 mg TID) may be utilized if contraindications to methocarbamol and cyclobenzaprine exist.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Opioid-Free Perioperative Pain Regimen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive no opioids. Pain will be managed with Acetaminophen 1000mg q8 hours, Ketorolac 10mg every 6 hours (for 5 days), Gabapentin 300mg q8 hours or Pregabalin 75mg twice daily, and a muscle relaxer (Methocarbamol 750mg BID or Cyclobenzaprine 5-10 mg TID) all to be taken as scheduled for the first 2 weeks (except Ketorolac - 5 days) postoperatively as side effects permit. Other NSAIDS (Naprosyn 500 mg BID or Ibuprofen 800 mg TID) may be utilized if contraindications to Ketorolac exist. Famotidine (20mg BID) or Omeprazole (20mg daily) will be prescribed along with NSAIDS for GI prophylaxis. Alternative muscle relaxers (Metaxalone 800 mg TID or Tizanidine 2-6 mg TID) may be utilized if contraindications to methocarbamol and cyclobenzaprine exist.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Opioid Analgesic</intervention_name>
    <description>Patients will be provided a prescription for low dose opioids for 5 days postoperatively (Hydrocodone/Acetaminophen 5/325mg or Oxycodone/Acetaminophen 5/325mg) to be taken every 6 hours as needed for pain. Refills may be provided (Hydrocodone/Acetaminophen 5/325mg or Oxycodone/Acetaminophen 5/325mg) if requested by the patient at the providers discretion. In addition, patients will also be prescribed Gabapentin 300mg q8 hours or Pregabalin 75mg twice daily and a muscle relaxer (Methocarbamol 750mg BID or Flexeril 5-10 mg TID) as needed for spasms. Alternative muscle relaxers (Metaxalone 800 mg TID or Tizanidine 2-6 mg TID) may be utilized if contraindications to methocarbamol and cyclobenzaprine exist.</description>
    <arm_group_label>Standard Perioperative Pain Regimen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Opioid-Free Postoperative Pain Regimen</intervention_name>
    <description>Patients will receive no opioids. Pain will be managed with Acetaminophen 1000mg q8 hours, Ketorolac 10mg every 6 hours (for 5 days), Gabapentin 300mg q8 hours or Pregabalin 75mg twice daily, and a muscle relaxer (Methocarbamol 750mg BID or Cyclobenzaprine 5-10 mg TID) all to be taken as scheduled for the first 2 weeks (except Ketorolac - 5 days) postoperatively as side effects permit. Other NSAIDS (Naprosyn 500 mg BID or Ibuprofen 800 mg TID) may be utilized if contraindications to Ketorolac exist. Famotidine (20mg BID) or Omeprazole (20mg daily) will be prescribed along with NSAIDS for GI prophylaxis. Alternative muscle relaxers (Metaxalone 800 mg TID or Tizanidine 2-6 mg TID) may be utilized if contraindications to methocarbamol and cyclobenzaprine exist.</description>
    <arm_group_label>Opioid-Free Perioperative Pain Regimen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Radiographic evidence of degenerative cervical spine disease&#xD;
&#xD;
          -  Failure of conservative therapy&#xD;
&#xD;
          -  Age â‰¥18 years&#xD;
&#xD;
          -  Skeletal maturity.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Preoperative chronic opioid use as determined by review of the CSMD (&gt;45 out of past&#xD;
             90 days) or self-report&#xD;
&#xD;
          -  History of chronic kidney disease&#xD;
&#xD;
          -  Revision cervical spine surgery&#xD;
&#xD;
          -  Concurrent posterior cervical fusion&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Amir M Abtahi, MD</last_name>
      <email>amir.m.abtahi@vumc.org</email>
    </contact>
    <contact_backup>
      <last_name>Kristin Archer, PhD</last_name>
      <email>kristin.archer@vumc.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 29, 2021</study_first_submitted>
  <study_first_submitted_qc>July 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 5, 2021</study_first_posted>
  <last_update_submitted>July 29, 2021</last_update_submitted>
  <last_update_submitted_qc>July 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University Medical Center</investigator_affiliation>
    <investigator_full_name>Amir Abtahi</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Analgesics, Opioid</mesh_term>
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

